These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14729863)

  • 1. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.
    Talmud PJ; Martin S; Taskinen MR; Frick MH; Nieminen MS; Kesäniemi YA; Pasternack A; Humphries SE; Syvänne M
    J Lipid Res; 2004 Apr; 45(4):750-6. PubMed ID: 14729863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
    Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
    J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
    Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
    BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
    ; Sarwar N; Sandhu MS; Ricketts SL; Butterworth AS; Di Angelantonio E; Boekholdt SM; Ouwehand W; Watkins H; Samani NJ; Saleheen D; Lawlor D; Reilly MP; Hingorani AD; Talmud PJ; Danesh J
    Lancet; 2010 May; 375(9726):1634-9. PubMed ID: 20452521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.
    Moreno R; Perez-Jimenez F; Marin C; Moreno JA; Gomez P; Bellido C; Perez-Martinez P; Jimenez-Gomez Y; Fuentes FJ; Lopez-Miranda J
    Atherosclerosis; 2006 Nov; 189(1):163-8. PubMed ID: 16386743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese.
    Liu H; Zhang S; Lin J; Li H; Huang A; Xiao C; Li X; Su Z; Wang C; Nebert DW; Zhou B; Zheng K; Shi J; Li G; Huang D
    Metabolism; 2005 May; 54(5):568-72. PubMed ID: 15877284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics.
    Wung SF; Aouizerat BE
    Res Theory Nurs Pract; 2003; 17(4):281-99; discussion 335-8. PubMed ID: 14959997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.
    Evans D; Buchwald A; Beil FU
    J Mol Med (Berl); 2003 Oct; 81(10):645-54. PubMed ID: 12937897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque.
    Rapp JH; Lespine A; Hamilton RL; Colyvas N; Chaumeton AH; Tweedie-Hardman J; Kotite L; Kunitake ST; Havel RJ; Kane JP
    Arterioscler Thromb; 1994 Nov; 14(11):1767-74. PubMed ID: 7947602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.